Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Genmab A/S CPSE:GMAB |
109,80 B | 14,29% | 4/6 | -4,48% | 51,64% | 31,40% | DOWN |
|
Ascendis Pharma A/S NasdaqGS:ASND |
14,41 B | 144,29% | 4/6 | 91,21% | 89,22% | 25,90% | UP |
|
ALK-Abelló A/S CPSE:ALK B |
45,78 B | 32,62% | 5/6 | 55,34% | 24,30% | 23,43% | UP |
|
Zealand Pharma A/S CPSE:ZEAL |
20,88 B | 71,10% | 4/6 | -51,93% | 89,61% | 69,15% | DOWN |
|
FluoGuide A/S OM:FLUO |
0,59 B | 0,00% | 2/4 | 0,00% | 0,00% | 105,22% | DOWN |
|
BioPorto A/S CPSE:BIOPOR |
0,51 B | -11,13% | 2/4 | 0,00% | 19,94% | -100,00% | DOWN |
|
Evaxion A/S NasdaqCM:EVAX |
0,03 B | 0,00% | 0/0 | -47,94% | -175,86% | 146,31% | DOWN |
|
Initiator Pharma A/S OM:INIT |
0,23 B | 0,00% | 2/4 | 0,00% | 0,00% | 190,24% | DOWN |
|
Strategic Partners A/S CPSE:STRAP |
0,03 B | 0,00% | 3/4 | 0,00% | 0,00% | -100,00% | DOWN |
|
IO Biotech NasdaqGS:IOBT |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | 10800,00% | DOWN |
|
Scandion Oncology A/S BST:8VY |
0,00 B | 0,00% | 3/4 | 0,00% | 0,00% | 0,00% | DOWN |
|
Forward Pharma A/S OTCPK:FWPA.Y |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
